請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25822完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 劉振軒(Chen-Hsuan Liu) | |
| dc.contributor.author | Liang-Tao Lin | en |
| dc.contributor.author | 林良道 | zh_TW |
| dc.date.accessioned | 2021-06-08T06:31:55Z | - |
| dc.date.copyright | 2006-07-28 | |
| dc.date.issued | 2006 | |
| dc.date.submitted | 2006-07-24 | |
| dc.identifier.citation | 劉振軒, 王綉真, 蘇豐振 and 傅千惠. (1997). 改良式免疫組織化學染色技術應用於福馬林液固定與石蠟包埋豬組織之研究. J Chin Soc Vet Sci, 23, 523-530.
Chen, X., Higgins, J., Cheung, S. T., Li, R., Mason, V., Montgomery, K., Fan, S. T., van de Rijn, M. and So, S. (2004). Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol, 17, 1198-1210. De Maria, R., Olivero, M., Iussich, S., Nakaichi, M., Murata, T., Biolatti, B. and Di Renzo, M. F. (2005). Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res, 65, 907-912. Dias Pereira, P., Carvalheira, J. and Gartner, F. (2004). Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue--an immunohistochemical study. Vet J, 168, 180-185. Dias Pereira, P. and Gartner, F. (2003). Expression of E-cadherin in normal, hyperplastic and neoplastic feline mammary tissue. Vet Rec, 153, 297-302. Gorlinger, S., Kooistra, H. S., van den Broek, A. and Okkens, A. C. (2002). Treatment of fibroadenomatous hyperplasia in cats with aglepristone. J Vet Intern Med, 16, 710-713. Hayes, A. A. and Mooney, S. (1985). Feline mammary tumors. Vet Clin North Am Small Anim Pract, 15, 513-520. Horvat, R., Hovorka, A., Dekan, G., Poczewski, H. and Kerjaschki, D. (1986). Endothelial cell membranes contain podocalyxin--the major sialoprotein of visceral glomerular epithelial cells. J Cell Biol, 102, 484-491. Kanemoto, K., Takahashi, S., Shu, Y., Usui, J., Tomari, S., Yan, K., Hamazaki, Y. and Nagata, M. (2003). Variable expression of podocyte-related markers in the glomeruloid bodies in Wilms tumor. Pathol Int, 53, 596-601. Kelley, T. W., Huntsman, D., McNagny, K. M., Roskelley, C. D. and Hsi, E. D. (2005). Podocalyxin: a marker of blasts in acute leukemia. Am J Clin Pathol, 124, 134-142. Kerjaschki, D., Sharkey, D. J. and Farquhar, M. G. (1984). Identification and characterization of podocalyxin--the major sialoprotein of the renal glomerular epithelial cell. J Cell Biol, 98, 1591-1596. Martin de las Mulas, J., Millan, Y., Bautista, M. J., Perez, J. and Carrasco, L. (2000a). Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Res Vet Sci, 68, 15-21. Martin de las Mulas, J., van Niel, M., Millan, Y., Blankenstein, M. A., van Mil, F. and Misdorp, W. (2000b). Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domest Anim Endocrinol, 18, 111-125. Martin de las Mulas, J., van Niel, M., Millan, Y., Ordas, J., Blankenstein, M. A., Van Mil, F. and Misdorp, W. (2002). Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status. Res Vet Sci, 72, 153-161. Millanta, F., Calandrella, M., Bari, G., Niccolini, M., Vannozzi, I. and Poli, A. (2005a). Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res Vet Sci, 79, 225-232. Millanta, F., Calandrella, M., Citi, S., Della Santa, D. and Poli, A. (2005b). Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential. Vet Pathol, 42, 30-34. Millanta, F., Lazzeri, G., Mazzei, M., Vannozzi, I. and Poli, A. (2002). MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis. Vet Pathol, 39, 120-126. Misdorp, W. (2002). Tumors of the Mammary Gland. In: Tumors in Domestic Animals, D. J. Meuten, Ed, Iowa State Press, Ames, Iowa, pp. 575-606. Misdorp, W., Else, R. W., Hellmen, E. and Lipscomb, T. P. (1999). Histological Classification of Mammary Tumors of the Dog and the Cat. World Health Organization, Washington, D.C. USA. Novosad, C. A. (2003). Principles of treatment for mammary gland tumors. Clin Tech Small Anim Pract, 18, 107-109. Ordas, J., Millan, Y., de los Monteros, A. E., Reymundo, C. and de las Mulas, J. M. (2004). Immunohistochemical expression of progesterone receptors, growth hormone and insulin growth factor-I in feline fibroadenomatous change. Res Vet Sci, 76, 227-233. Overley, B., Shofer, F. S., Goldschmidt, M. H., Sherer, D. and Sorenmo, K. U. (2005). Association between ovarihysterectomy and feline mammary carcinoma. J Vet Intern Med, 19, 560-563. Preziosi, R., Sarli, G., Benazzi, C., Mandrioli, L. and Marcato, P. S. (2002). Multiparametric survival analysis of histological stage and proliferative activity in feline mammary carcinomas. Res Vet Sci, 73, 53-60. Preziosi, R., Sarli, G., Benazzi, C. and Marcato, P. S. (1995). Detection of proliferating cell nuclear antigen (PCNA) in canine and feline mammary tumours. J Comp Pathol, 113, 301-313. Raharison, F. and Sautet, J. (2006). Lymph drainage of the mammary glands in female cats. J Morphol, 267, 292-299. Ramos-Vara, J. A. (2005). Technical aspects of immunohistochemistry. Vet Pathol, 42, 405-426. Shi, S. R., Chaiwun, B., Young, L., Cote, R. J. and Taylor, C. R. (1993). Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem, 41, 1599-1604. Shi, S. R., Key, M. E. and Kalra, K. L. (1991). Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem, 39, 741-748. Skorupski, K. A., Overley, B., Shofer, F. S., Goldschmidt, M. H., Miller, C. A. and Sorenmo, K. U. (2005). Clinical characteristics of mammary carcinoma in male cats. J Vet Intern Med, 19, 52-55. Somasiri, A., Nielsen, J. S., Makretsov, N., McCoy, M. L., Prentice, L., Gilks, C. B., Chia, S. K., Gelmon, K. A., Kershaw, D. B., Huntsman, D. G., McNagny, K. M. and Roskelley, C. D. (2004). Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res, 64, 5068-5073. Takeda, T., Go, W. Y., Orlando, R. A. and Farquhar, M. G. (2000). Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol Biol Cell, 11, 3219-3232. Viste, J. R., Myers, S. L., Singh, B. and Simko, E. (2002). Feline mammary adenocarcinoma: tumor size as a prognostic indicator. Can Vet J, 43, 33-37. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25822 | - |
| dc.description.abstract | 乳腺腫瘤在貓是一種常見的腫瘤，貓隻一旦患有乳腺腫瘤，其惡性的機會遠高於良性，容易轉移至淋巴結及體內其他的臟器，預後多不佳。許多的預後指標及生物標記，透過統計學的分析其與乳腺腫瘤的預後的相關性，以期能輔助診斷腫瘤預後。1980年代末期Podocalyxin被從大鼠的腎絲球體內皮細胞分離出來，並被認為具有抗細胞黏附的功能，Podocalyxin的存在會使得細胞較不容易與周邊的細胞及基底膜黏附。本研究的目的在於了解Podocalyxin在貓乳腺腫瘤中的表現，並分析其與組織病理學上的關聯性。本實驗回溯收集了32個貓乳腺腫瘤的外科切除之病材進行病歷資料分析、Podocalyxin及PCNA抗原之免疫組織化學染色，最後以統計學的方法分析其表現的結果。結果顯示32貓乳腺腫瘤病例的平均診斷年齡為9.7 ± 2.87（mean ± SD）歲，品種方面以短毛家貓（domestic short hair, DSH）最多（53.1%, 17/32），波斯貓（Persian）次之（21.8%, 7/32）。腫瘤的良惡性比為1:3，惡性腫瘤當中以tubulopapillary carcinoma，共計14例為最多。免疫組織化學染色結果首次證實Podocalyxin確實存在貓這種（species）動物的絲球體、血管內皮以及部分的骨骼肌當中，在乳腺腫瘤的部分亦會有陽性的訊號出現；在惡性乳腺腫瘤細胞上、轉移至周邊淋巴結的腫瘤細胞及侵犯至血管淋巴管的腫瘤細胞有較強的陽性訊號，其表現在統計學上顯著地高於在正常乳腺及良性增生乳腺的表現（p < 0.05）；在良性腫瘤的表現亦顯著地高於在正常乳腺的表現（p < 0.05）。PCNA的免疫組織化學染色結果顯示其在良性及惡性的腫瘤的表現上並沒有顯著的差異（p > 0.05）。依結果推斷，Podocalyxin在貓的乳腺腫瘤的惡性化及轉移似乎具有功能性的相關，具有潛力成為一個評估預後的生物標記。 | zh_TW |
| dc.description.abstract | Mammary gland tumors (MGTs) are frequently encounted neoplasm in cats, and its ratio of malignancy is higher, so easy metastases cause poor prognosis. Many prognostic factors and biomarkers are studied and reported to assist the pathology diagnosis and prognosis. Podocalyxin was isolated in 1980’s from glomerular epithelium (podocyte) in rats, and is considered a function “anti-adhesion”. The function of anti-adhesion makes cells separate with each other and basement membrane. The objective of this study is to study the expression and malignancy prediction of Podocalyxin in feline mammary gland tumors. Thirty-two feline MGTs cases were retrospectively collected for basic information analysis and immunohistochemistry (IHC) of Podocalyxin and PCNA. The mean age of MGT affected cats was 9.7 year-old, and the first and second predisposing breed were Domestic Short Hair (DSH) (53.1%, 17/32) and Persian (21.8%, 7/32). The ratio of benign tumors and malignant tumors was 1:3. The result of IHC for Podocalyxin showed significant difference between malignant/metastastic neoplastic cells to normal/ hyperplastic cells (p < 0.05). The expression of Podocalyxin also had significant difference between hyperplastic/benign and normal cells. The expression for PCNA showed no significant difference between benignancy and malignancy. Based on the result, it is hypothesized that the expression of Podocalyxin is correlated to the malignance and metastasis, and Podocalyxin has a potential to be a prognostic biomarker in feline mammary gland tumors. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T06:31:55Z (GMT). No. of bitstreams: 1 ntu-95-R93629017-1.pdf: 959283 bytes, checksum: 315aa8a7811753c9226a3d92787c1e5d (MD5) Previous issue date: 2006 | en |
| dc.description.tableofcontents | 目錄
目錄 -------------------------------------------------------------------------------- I 圖次 -------------------------------------------------------------------------------- III 表次 -------------------------------------------------------------------------------- IV 中文摘要 -------------------------------------------------------------------------- V 英文摘要 ------------------------------------------------------------------------- VI 第一章 前言 -------------------------------------------------------------------- 1 第二章 文獻探討 第一節 貓乳腺腫瘤（feline mammary gland tumors）------------------ 3 第二節 貓乳腺腫瘤的分類及其病理特徵 ----------------------------- 4 第三節 貓乳腺腫瘤預後因子之探討 ----------------------------------- 8 第四節 Podocalyxin之簡介 ----------------------------------------------- 11 第五節 免疫組織化學染色（Immunohistochemistry, IHC）----------- 12 第三章 實驗材料與方法 第一節 貓乳腺腫瘤病例之收集 ----------------------------------------- 17 第二節 肉眼病理學檢查 -------------------------------------------------- 17 第三節 組織病理學檢查 -------------------------------------------------- 17 第四節 免疫組織化學染色 ----------------------------------------------- 19 第五節 免疫組織化學染色結果判讀 ----------------------------------- 21 第四章 實驗結果 第一節 貓乳腺腫瘤臨床資料分析 -------------------------------------- 25 第二節 貓乳腺腫瘤肉眼病理學形態 ----------------------------------- 25 第三節 貓乳腺腫瘤組織病理學形態 ----------------------------------- 25 第四節 Podocalyxin於貓乳腺腫瘤中之表現分析 -------------------- 26 第五節 PCNA於貓乳腺腫瘤中之表現分析 --------------------------- 27 第五章 討論 一、貓乳腺腫瘤臨床資料及組織病理學 ---------------------------------- 39 二、貓乳腺腫瘤及組織病理學 ---------------------------------------------- 39 三、Podocalyxin免疫組織化學染色 --------------------------------------- 40 四、Podocalyxin於貓乳腺腫瘤之表現 ------------------------------------ 40 五、Podocalyxin之表現於腫瘤預後之探討 ------------------------------ 41 六、PCNA於貓乳腺腫瘤之表現 ------------------------------------------- 42 第六章 參考文獻 -------------------------------------------------------------- 43 | |
| dc.language.iso | zh-TW | |
| dc.subject | 預後 | zh_TW |
| dc.subject | 貓 | zh_TW |
| dc.subject | 乳腺腫瘤 | zh_TW |
| dc.subject | Podocalyxin | en |
| dc.subject | mammary gland tumor | en |
| dc.subject | cat | en |
| dc.subject | prognosis | en |
| dc.title | Podocalyxin於貓乳腺腫瘤之表現及其作為良惡性腫瘤生物標記之探討 | zh_TW |
| dc.title | The Expression and Malignancy Prediction of Podocalyxin as a Biomarker in Feline Mammary Gland Tumors | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 94-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 楊智偉,潘銘正,林中天,李進成(Chin-Cheng Lee) | |
| dc.subject.keyword | 貓,乳腺腫瘤,預後, | zh_TW |
| dc.subject.keyword | Podocalyxin,cat,mammary gland tumor,prognosis, | en |
| dc.relation.page | 46 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2006-07-25 | |
| dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
| dc.contributor.author-dept | 獸醫學研究所 | zh_TW |
| 顯示於系所單位： | 獸醫學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-95-1.pdf 未授權公開取用 | 936.8 kB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。